Feature Channels
Stem Cells
Filters:
ScienceChannels:Keywords: |
Stem Cell Success: One Couple’s Effort to Protect Their Son From Fatal Nerve Disease Will Help Other Boys Too
 A new human embryonic stem cell line containing the genetic mutation for adrenoleukodystrophy (ALD), and neurons grown from those cells, are now helping scientists study the condition -- thanks to an embryo donated by a couple seeking to avoid passing the disease to their son. |
Released: 19-Jan-2015 4:00 PM EST
University of Michigan Health System |
MedicineChannels:Stem Cells, Regenerative Medicine, Journal Related News, Grant Funded News, Featured: DailyWire, Featured: MedWire, Aging, Biotech, Cell Biology, Healthcare, Seniors, Staff Picks, Top Clipped Stories
Keywords: |
Bone Stem Cells Shown to Regenerate Bone and Cartilage in Adult Mice
A stem cell capable of regenerating both bone and cartilage has been identified in bone marrow of mice. |
Released: 15-Jan-2015 3:00 PM EST
Columbia University Medical Center |
MedicineChannels: |
Scientists Develop Pioneering Method to Define Stages of Stem Cell Reprogramming
 UCLA researchers have for the first time developed a method that defines many stages of reprogramming skin or blood cells into pluripotent stem cells. Study analyzed the reprogramming process at the single-cell level on a daily basis. Results determined that stages of cell change were the same across different reprogramming systems and cell types analyzed. |
Released: 5-Jan-2015 12:00 PM EST
UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research |
MedicineChannels:Keywords: |
New Published Paper Shows Placental Cells Protect Neurons
Placental cells could potentially be used to treat stroke or other injuries to the nervous system attributable to low oxygen or glucose levels according to newly published study. |
Released: 5-Jan-2015 6:00 AM EST
Pluristem Therapeutics |
MedicineChannels:Keywords: |
'Bad Luck' of Random Mutations Plays Predominant Role in Cancer, Study Shows
Scientists from the Johns Hopkins Kimmel Cancer Center have created a statistical model that measures the proportion of cancer incidence, across many tissue types, caused mainly by random mutations that occur when stem cells divide. By their measure, two-thirds of adult cancer incidence across tissues can be explained primarily by “bad luck,” when these random mutations occur in genes that can drive cancer growth, while the remaining third are due to environmental factors and inherited genes. |
Embargo expired: 1-Jan-2015 2:00 PM EST
Released: 30-Dec-2014 3:15 PM EST
Johns Hopkins Medicine |
MedicineChannels:Keywords: |
Reprogramming Stem Cells May Prevent Cancer After Radiation
 University of Colorado Cancer Center study shows that pre-programmed stem cell demise allows cancer after radiation, and that NOTCH signaling can restore stem cell function. |
Released: 29-Dec-2014 12:00 PM EST
University of Colorado Cancer Center |
ScienceChannels:Keywords: |
In a First, Weizmann Institute and Cambridge University Scientists Create Human Primordial Germ Cells
 Weizmann’s Dr. Jacob Hanna and Cambridge University scientists have made a first-in-the-world breakthrough: creating human primordial cells. The group has turned back the clock on human cells to create primordial germ cells: the embryonic cells that give rise to sperm and ova. Scientists worldwide have been pursuing this goal for several years. |
Released: 24-Dec-2014 1:00 PM EST
Weizmann Institute of Science |
MedicineChannels:Keywords: |
Test Predicts Response to Early Treatment for Dangerous Complication of Stem Cells Transplants Used in Leukemia Patients
A new test may reveal which patients will respond to treatment for graft versus host disease (GVHD). |
Embargo expired: 22-Dec-2014 6:30 PM EST
Released: 20-Dec-2014 5:00 PM EST
Mount Sinai Medical Center |
ScienceChannels:Keywords: |
Discovery Links Shift in Metabolism to Stem Cell Renewal
 Stem cells in early embryos have unlimited potential; they can become any type of cell, and researchers hope to one day harness this rejuvenating power to heal disease and injury. To do so, they must, among other things, figure out how to reliably arrest stem cells in a Peter Pan-like state of indefinite youth and potential. |
Released: 10-Dec-2014 1:00 PM EST
Rockefeller University |
MedicineChannels: |
New Development in Cell Therapy: Veto Cell Technology
Overcoming graft rejection is the main obstacle when it comes to stem cell regeneration or organ transplantation. Scientists are investigating whether Veto Cell technology, which selectively tunes immune response, can change how immunologists treat blood cancers and bone marrow transplants, as well as the process of how organs are repaired and new ones are regenerated. Itamar Shimat, Cell Source’s CEO is available to talk about his company’s recent breakthroughs with Veto Cell technology. |
Released: 5-Dec-2014 9:05 AM EST
Expert Available Cell Source |
